Shares of UiPath surged as much as 9.2% to $12.80 on Monday as investors continued digesting a quarter that checked nearly every box: a revenue beat, a historic profitability milestone, and a raised full-year forecast. The question now is whether the follow-through buying reflects a genuine inflection point or simply relief after a long slide — the stock still trades near the bottom of its 52-week range.
A $20 Million Revenue Beat Signals Stronger Enterprise Demand. UiPath reported Q1 revenue of $418.4 million, crushing the Street consensus of $397.5 million and growing 17% year-over-year.
Management raised fiscal 2027 revenue guidance to $1.776–$1.781 billion, up from the prior $1.754–$1.759 billion range — a lift larger than the beat itself, signaling confidence beyond one strong quarter.
AI-infused deals are running six times larger than deals without AI components , suggesting the company's pivot to AI-powered automation is landing with big-ticket buyers.
First GAAP Profit Marks a Turning Point for Credibility. Non-GAAP operating income hit $92 million at a 22% margin, while GAAP operating income turned positive at $28 million — versus a $16 million loss a year ago. For a company that has burned cash for years, crossing into GAAP profitability removes a persistent overhang and could broaden the investor base to funds that screen out money-losers. UiPath also repurchased 20 million shares at an average of $11.47 during Q1, backstopping the stock with its $1.4 billion cash position and zero debt.
Analysts Are Cautious Despite the Beat. BofA raised its price target to $13 from $12 but kept an Underperform rating.
Morgan Stanley cut its target to $15 from $17, calling the results "solid" but describing the subscription-revenue trajectory as still in "show-me" territory. The recurring-revenue base — subscriptions customers pay annually, known as ARR — grew 11% to $1.901 billion , decent but not accelerating fast enough for skeptics. BofA wants "more data points that support a sustainable ARR growth acceleration trajectory" before turning constructive.
The Bigger Picture: AI Is Reshaping the Deal Mix, but Competition Is Fierce. Sixteen of UiPath's top 20 deals in the quarter included AI-agent modules , evidence the product portfolio is evolving. Yet risks remain: macro uncertainty, currency headwinds, and customer losses concentrated among smaller accounts could cap upside. At roughly $12.80, the stock sits well below the analyst consensus target near $14, leaving room for appreciation — if the next few quarters prove Q1 wasn't an outlier.